Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/227,311external-prioritypatent/US5064646A/en
Application filed by Univ MarylandfiledCriticalUniv Maryland
Priority to FI972658ApriorityCriticalpatent/FI101603B1/en
Publication of FI972658A0publicationCriticalpatent/FI972658A0/en
Publication of FI972658LpublicationCriticalpatent/FI972658L/en
Application grantedgrantedCritical
Publication of FI101603BpublicationCriticalpatent/FI101603B/en
Publication of FI101603B1publicationCriticalpatent/FI101603B1/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Peptides Or Proteins
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
A new virus, which is not neutralized by monoclonal antibodies that bind with and neutralize all present IBD vaccines, and is capable of inducing infectious bursal disease in poultry, has been identified, in substantially pure form. A process for the preparation of a vaccine against said virus is disclosed.
FI972658A1988-08-021997-06-19
Method for producing vaccine against the communicable bursal disease of poultry
FI101603B1
(en)
Peptide antigen analog of a native peptide antigen vaccine antibody process to vaccinate a host in need of this treatment kit diagnostic processes to prepare an antigen analog of a native peptide antigen to prepare a vaccine to analyze a sample for a peptide antigen native and to analyze a sample for an antibody
Vaccine against diseases caused by reo viruses, combined vaccine with newcastle disease virus, process for preparing them and reo virus strain used for their preparation